FDA
approval
· 2026-02-05
FDA Approved: CARBIDOPA, LEVODOPA AND ENTACAPONE — Original Application (Alembic Pharmaceuticals Inc.)
Summary
The FDA approved the original application for a generic fixed-dose combination of carbidopa, levodopa, and entacapone for Parkinson's disease. This represents a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for CARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA, LEVODOPA AND ENTACAPONE)